Publication not explained
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
Featured Image
Read the Original
This page is a summary of: Transcriptional down-regulation of c-myc expression in an erythroleukemic cell line, K562, and its doxorubicin-resistant variant by two topoisomerase II inhibitors, doxorubicin and amsacrine, Anti-Cancer Drugs, March 1998, Wolters Kluwer Health,
DOI: 10.1097/00001813-199803000-00007.
You can read the full text:
Contributors
The following have contributed to this page
